⬆
X
By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,

Comparison results

 
Results: Differences General ✘Oligomenorrhea✘Cervical leukoplakia
Related research Analogs Analogs
Register, to see more distinctive signs of diseases and studies 42%(16)16%(4)
Gynecologist's examination 5%(0)21%(0)
Infection tests —15%(0)
Thyroid hormones 15%(5)—
Distinctive symptoms
Register, to see more distinctive signs of diseases and studies 100%—
Register, to see more distinctive signs of diseases and studies —95%
endometrioid ovarian cyst 11% —
cervical leukoplakia — 40%
pain before menstruation 10% —
gastritis — 30%
cyst of the left ovary 9% —
endocervicitis — 27%
ovarian cysts 9% —
cervical diathermocoagulation — 23%
worse during menstruation 9% —
human papillomavirus — 23%
menstruation disorder 8% —
cervical erosion — 23%
polycystic ovaries 8% —
cervical resection — 21%
polycystic 7% —
postpartum cervical ulcer — 21%
cystic fibrosis 7% —
mucous whites — 20%
stopped menstruation 7% —
eroded uterine lining — 20%
abnormalities of uterine development 7% —
warts — 20%
primary and secondary amenorrhea 7% —
intra-phase infections 4% 23%
adrenogenital syndrome 6% —
vulvovaginitis 4% 23%
aper syndrome 6% —
vulva infections 4% 23%
kalman syndrome 6% —
vaginal sarcoma — 19%
uterine atresia 6% —
hyperkeratosis — 19%
hyperandrogenism in women 6% —
uterine tumor — 19%
cysts 6% —
scarring of the cervix — 19%
testicular feminization syndrome 6% —
cervical pregnancy — 18%
secondary amenorrhea 6% —
cervical hypertrophy — 18%
prolactin deficiency 6% —
cervical cancer — 18%
vaginal atresia 6% —
ureaplasmosis in women — 17%
uterine cyst 6% —
uterine cancer — 17%
testicular atrophy 5% —
fine-grained — 16%
ovarian insufficiency 5% —
cervix is deformed — 16%
shereshevsky-turner syndrome 5% —
STDs — 16%
hair loss 5% —
ureaplasmosis and mycoplasmosis — 16%
ovarian hypofunction 5% —
clamidiosis in women — 16%
monthly meager and short 5% —
vaginal discharge — 15%
empty' Turkish saddle syndrome 5% —
hypertrophy of the uterine body — 15%
pimples on the body 5% —
hpv dna positive — 15%
uterine hypoplasia 5% —
endocrine infertility — 15%
ascherman syndrome 5% —
ureaplasmosis — 15%
hirsutism 5% —
mycoplasmosis in women — 15%
hyperprolactinemia 5% —
progesterone deficiency — 14%
fsh deficiency 5% —
hypertrophic scar — 14%
pituitary tumors 5% —
white with an unpleasant odor — 14%
uterine appendages are increase 5% —
cancer 2% 16%
rash on the body 4% —
short cervix — 14%
development of external genital organs is incorrect 4% —
bloody discharge from the vagina — 13%
complete lack of appetite 4% —
lymphosarcoma — 13%
can not get pregnant 4% —
excess progesterone 3% 16%
congenital hyperplasia of the adrenal cortex 4% —
scar on the uterus — 13%
menopause 4% —
mycoplasma — 12%
exhaustion 4% —
rashes symmetrical — 12%
secondary hyperaldosteronism 4% —
salpingitis — 12%
empty 4% —
clamidiosis — 12%
endometrial cancer 4% —
inflammation of the ovaries — 12%
ovarian hypoplasia 4% —
adnexitis — 12%
premenopause 4% —
vaginitis — 12%
to increase the mammary glands 4% —
abortions 2% 14%
rashes on the face 4% —
inflammation 4% 16%
prolactinoma 4% —
uterine infertility 2% 13%
ovarian endometriosis 4% —
trauma 2% 13%
congenital adrenal hyperplasia 4% —
from sex worse 2% 13%
ovulatory syndrome 4% —
birth trauma — 11%
panhypopituitarianism 4% —
angioplasty — 11%
hyperaldosteronism 4% —
oncology 4% 15%
effects of taking hormones 4% —
vaccination — 10%
head tumor 4% —
clear boundaries — 10%
sheehan syndrome 4% —
cytomegalovirus — 10%
increased hairiness 4% —
skin cancer — 10%
resistant ovary syndrome 4% —
no discharge — 10%
increased 4% —
history of surgery 5% 14%
dysfunctional uterine bleeding 4% —
herpes — 9%
hypogonadism 4% —
anovulatory infertility 5% 14%
pimples on the head 4% —
aggressive — 9%
pimples on the face 4% —
peptic ulcer — 9%
sports amenorrhea 4% —
omission of internal organs 2% 10%
excess testesterone 4% —
consequences of infection 3% 11%
acne face 4% —
anovulation 6% 14%
acne 4% —
consequences of injuries — 8%
obesity 4% —
scarring 2% 9%
itsenko-cushing syndrome (hypercorticism) 4% —
impaired uterine function 7% 14%
swyer syndrome 4% —
amenorrhea 4% 11%
bipolar disorder 3% —
early development 2% 9%
painful swelling 3% —
periodic illness 2% 8%
anxiety 3% —
surgical infections 2% 8%
baldness in women 3% —
menstruation irregular 10% 16%
follicular ovarian cyst 3% —
endometritis 5% 11%
aversion to milk 3% —
appendages of the uterus 7% 13%
effects of hormone 3% —
consequences of pregnancy 4% 9%
cyst of the yellow body of the ovary 3% —
роды и вскармливание 6% 11%
syphilitic meningitis 3% —
there are no complaints 3% 8%
consequences of surgery 3% —
shortened cycle 6% 10%
hematocolpos 3% —
pituitary gland diseases 6% 10%
hematosalpinx 3% —
ovarian dysfunction 7% 11%
excess of dhea 3% —
skin problems 3% 7%
endometriosis 3% —
long monthly cycle 9% 12%
aversion to dairy products 3% —
monthly short 10% 13%
reduction of ovarian reserve 3% —
lowered 4% 7%
tuberculous meningitis 3% —
patient's condition 4% 7%
affective disorders 3% —
hormonal disorders 10% 12%
metabolic syndrome 3% —
consequences of taking medications 5% 7%
live birth 3% —
pancreatopathy 3% —
neuroses in children 3% —
lactation 3% —
chronic headaches 3% —
postpartum endometritis 3% —
longing 3% —
vulvar dysplasia 3% —
pain in the nipples 3% —
up mania 3% —
hematometer 3% —
rashes on the head 3% —

Instructions

Video
  1. Introduce new diseases through 🔍 Search and input on the top panel using
  2. The table shows the most important distinguishing symptoms, tests and diagnoses related to the selected diseases.
  3. The higher the percentage, the more important this symptom is for the disease and vice versa. At 0%, we can say that this symptom never occurs in the disease.
  4. The list changes dynamically depending on the data of the current visit in the selection of therapy .
  5. Click on the percentageto see the suggestions from the original source.
  6. By using the service, you agree to user agreement.